Form D · Other
Trace Genomics, Inc.
Redwood City, CA · CIK 0001741875
Offering snapshot reported Nov 23, 2021 · SEC filing
- Reported sold
- $8.34M Offering amount: $10M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2021 | Initial | $8,336,517 | No comparison | 8 | SEC filing |
| Jul 10, 2020 | Amendment | $17,196,258 | $3,072,920vs Jun 1, 2020 | 14 | SEC filing |
| Jun 1, 2020 | Initial | $14,123,338 | No comparison | 7 | SEC filing |
| Dec 14, 2018 | Amendment | $19,721,869 | $4,843,459vs May 30, 2018 | 20 | SEC filing |
| May 30, 2018 | Initial | $14,878,410 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-422321
Source: Form D, filed Nov 23, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Buckner | Director |
| Veery Maxwell | Director |
| Poornima Parameswaran | Director, Executive |
| Joe Pianelli | Director |
| Cristina Rohr | Director |
| Michael Toelle | Director |
| Daniel Vradenburg | Director, Executive |
| Diane Wu | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
303 Twin Dolphin Drive Fl6 #35
Redwood City, CA, 94065
Redwood City, CA, 94065